Patent ID: 9233070
Filing Date: 2016-01-12
CPC Classification: A61F,A61K,A61P

Claim Text:
1. A method of treating an ocular condition of an eye of a patient, comprising the step of placing a biodegradable intraocular implant into the vitreous of an eye of the patient, the implant comprising a TKI and a biodegradable polymer, wherein the implant releases TKI at a rate effective to sustain release of the TKI from the implant for at least about one week to about one year after the implant is placed in the vitreous of the eye to treat the ocular condition; wherein the tyrosine kinase inhibitor is provided in an amount from about 30% by weight to about 70% by weight of the implant, and the biodegradable polymer comprises a poly(lactide-co-glycolide) in an amount from about 30% by weight to about 70% by weight of the implant.